Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fotolon photodynamic therapy for airway-obstructing non-small cell lung cancer
2013-001876-39Phase 2Completed
- Sponsor
- ApoCare Pharma
- Start
- Mar 2014
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of chlorin e6 in non-small cell lung cancer (NSCLC), sponsored by ApoCare Pharma. Primary endpoint: Objective tumor response rate. Started Mar 2014; status: completed.
02
Drugs
chlorin e6
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2013-001876-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001876-39.